Hotpennystocknews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 01/17/2014 -- Hotpennystocknews.com issues special report on - BHP Billiton Limited (BHPLF),Roche (OTCMKTS:RHHBY)
BHP Billiton Limited (BHPLF) is a diversified natural resources company.The Company operates nine customer sector groups: petroleum, aluminium, base metals (including uranium), diamonds and specialty products, stainless steel materials, iron ore, manganese, metallurgical coal and energy coal.
BHPLF said that it has appointed Tony Cudmore as President, Corporate Affairs. Tony will join the Group Management Committee or GMC and commence in his role on 3 March 2014. He will report to the Chief Executive Officer Andrew Mackenzie and will be based at the Company’s headquarters in Melbourne, Australia.
BHP Billiton Limited (ADR) (BHP) stock opened at $64.39, in last session and closed at $64.95, by losing 0.00%. The 52 week range of the stock is $55.66 – $80.54. Company’s market capitalization is $104.29 billion.
Get Analysts Report On BHPLF, Here.
Headquartered in Basel, Switzerland, Roche (OTCMKTS:RHHBY) is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, infectious diseases, inflammation, metabolism and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2012 Roche had over 82,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 45.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
RHHBY reported decline -1.57% and closed at $69.53 with the total traded volume of 536,026.00 shares. Its market capitalization is $ 628,602.00. The stock has a 52-week high price of 71.85 and its 52-week low was recorded at $52.70.
Has RHHBY Found The Bottom and Ready To Move Up? Find Out Here.
Neither Hotpennystocknews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by Hotpennystocknews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.Hotpennystocknews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Hotpennystocknews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in.
Read Full disclaimer at:http://www.hotpennystocknews.com/disclaimer.php
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)